Has Anne Blake, MD received payments from drug or device companies?

Yes. Drug and device makers reported $3,020 in general payments to Anne Blake, MD across 75 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Anne Blake, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Anne Blake, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Anne Blake, MD

Dermatology · Leawood, KSNPI 1750655585

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.5% of the total across 75 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 13.6% — the pattern of someone who eats at a lot of different presentations.

$3,020in general payments, 2019–2025

Across 75 payments — averaging $40.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$411
Pfizer$376
Regeneron Healthcare Solutions, Inc.$347
Novartis$312
Lilly USA, LLC$218
E.r. Squibb & Sons, L.L.C.$168
plus $1K from 14 others

$575,173in research payments, 2019–2025

Across 53 payments — averaging $10,852 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

AbbVie$575K

What the payments were for

Food & beverage$3,00599%
Education$151%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	13	$411
Pfizer	13	$376
Regeneron Healthcare Solutions, Inc.	3	$347
Novartis	18	$312
Lilly USA, LLC	4	$218
E.r. Squibb & Sons, L.L.C.	3	$168
Galderma Laboratories, L.p.	4	$163
Organogenesis Inc.	1	$145
Sun Pharmaceutical Industries Inc.	2	$136
Dermavant Sciences, Inc.	3	$111
Bristol Myers Squibb	1	$111
Arcutis Biotherapeutics, Inc.	1	$111
Incyte Corporation	1	$106
Stemline Therapeutics Inc.	1	$105
Almirall LLC	1	$86
LEO Pharma Inc.	2	$39
Fresenius Kabi USA, LLC	1	$22
Hydrofera LLC	1	$22
Boehringer Ingelheim	1	$19
Johnson & Johnson	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

DUPIXENT$347
ILUMYA$122
LITFULO$112
Otezla$111
ZORYVE$111
OPZELURA$106

How this compares

$3,020 in reported general payments places this provider in the 60th percentile of 82 dermatology providers in Kansas.

See all dermatology providers in Kansas →

Medicare billing

Part B allowed, 2024

$288,244

Medicare patients

1,065

Services billed

4,286

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Dupixent PenDupilumab	13	$52,388
Clobetasol Propionate	94	$3,418
Ketoconazole	156	$2,731
Fluocinonide	67	$2,125
Metronidazole	38	$2,008
Fluorouracil	26	$1,798
Doxycycline Hyclate	72	$1,663
Triamcinolone Acetonide	202	$1,556
Betamethasone Dipropionate	35	$1,542
Tretinoin	27	$1,382
Tacrolimus	17	$1,194
Clindamycin Phosphate	30	$1,074
Cephalexin	28	$915
Finasteride	65	$707
Fluocinolone AcetonideFluocinolone/Shower Cap	12	$579

Paid to pharmacies, not to this prescriber.

Other dermatology in Leawood

Kyle AndersonLeawood$23K
Celeste AngelLeawood$6K
Karen NeubauerLeawood$6K
Colin RuffLeawood$3K
James AllenLeawood$3K
Viseslav Tonkovic CapinLeawood$851
David KaplanOverland Park$489K
Meena SinghOverland Park$181K
Daniel AiresKansas City$83K
Dominic WuShawnee Mission$51K

See the full list for Kansas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →